Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes

ID#: NCT04345393

Age: 18 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: May 14, 2022

End Date: March 01, 2024

Contact Information:
Drew Helmus, MPH, MA
212-824-7786
Summary: Delivery of healthcare has been traditionally limited to in-person visits or hospitalizations, while patients spend the majority of their time at home or work. Digital Medicine (e.g. apps, remote monitoring, telemedicine, patient reported outcomes) has the potential to bridge this gap, but the question remains as to how to translate it to mainstream practice while providing individualized recommendations to improve population health across organizations. Through the creation of a Digital Transformation Network (DTN) for Inflammatory Bowel Disease (IBD), the study team plans to reduce digital disparities and scientifically test the impact of these technologies in a clinical trial in three CTSA sites catering to diverse populations and communities.
Eligibility:

Inclusion Criteria:

- Patients with confirmed Inflammatory Bowel Disease (IBD) will be enrolled into DTN in stepped-wedge cluster randomized trial

- Age greater than or equal to 18 years

- Ability to speak or understand English or Spanish Language.

Exclusion Criteria:

- Condition or disease that, in the opinion of the investigators, may make it exceedingly difficult for the patient to use DTN, including, but not limited to, advanced dementia.
Find a Clinical Trial Find Cancer Clinical Trials